does semaglutide affect your liver A study from the New England Journal of Medicine found new evidence that GLP-1 drugs, like Ozempic and Wegovy, used for diabetes and obesity could also help people with a type of disease. CBS Semaglutide Showing Promise in Treating

2018;73(Suppl 1):S48S56

For type 1 patients, the most critical safety consideration is hypoglycemia risk when insulin and GLP-1 are combined

How much is uncertain, but studies have indicated that anywhere between 15% to 60% of the weight people lose is lean muscle mass meaning that if you shed 50 pounds, you will potentially be losing 7.5 to 30 pounds of your lean muscle

Most patients begin at the lowest effective dose and titrate upward every 24 weeks until reaching the optimal response threshold

In this scenario, a deeper understanding of the tissue specificity effects and the molecular mechanisms of PPAR- is mandatory to develop novel and safer therapies

Access will be uneven